ClinicalThought

Share

Program Content

Activities

  • IO in TNBC: irAE Management
    How I Manage Toxicities Associated with Immune Checkpoint Inhibition in My Patients with Metastatic TNBC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 16, 2020

    Expires: March 15, 2021

  • IO for Metastatic TNBC
    How I Am Using Immunotherapy in the Management of Metastatic TNBC
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 02, 2020

    Expires: April 01, 2021

  • IO for Early-Stage TNBC
    Moving Immunotherapy Into Earlier Settings for Triple-Negative Breast Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 17, 2020

    Expires: April 16, 2021

  • Combination IO for mTNBC
    Future Directions in Combination Immunotherapy Strategies for Metastatic Triple-Negative Breast Cancer
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 27, 2020

    Expires: April 26, 2021

Faculty

cover img faculity

Sarah Donahue, MPH, NP

Breast Medical Oncology Nurse Practitioner
Hellen Diller Comprehensive Cancer Center
University of California San Francisco
San Francisco, California

cover img faculity

David B. Page, MD

Assistant Member, Medical Oncology
Medical Oncologist
Providence Cancer Institute
Providence Health & Services
Portland, Oregon

cover img faculity

Hope S. Rugo, MD

Clinical Professor of Medicine
UCSF Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California

cover img faculity

Peter Schmid, MD, PhD, FRCP

Centre Lead
Centre of Experimental Cancer Medicines
Barts Cancer Institute
Clinical Director
St Bartholomew Breast Cancer Centre
Barts Hospital
London, United Kingdom

Provided by

ProCE Banner

Supporters

Genentech TEXT Only